has announced a $10 million gift from Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, for a new targeted cell therapy center at its .
The gift will establish the Stanford Center for Cancer Cell Therapy and support research on treatments that harness a patient's own immune system to attack and kill tumor cells. The center will be led by Crystal Mackall, professor of pediatrics and medicine and one of the pioneers in the field of cancer cell therapy, and is expected to complement the work of the at Stanford, which Mackall also directs.
Jeffrey Rothschild, a former vice president of infrastructure engineering at Facebook, has co-founded several technology companies, including and Mpath Interactive, and currently is an advisor and partner at the venture firm . The Rothchilds' philanthropy has focused on health care and education, including scholarships for students who might not otherwise be able to attend school. Five years ago, they established an eye hospital in western Kenya, where clinicians now provide care at little or no cost to thirty-five hundred patients a year suffering from cataracts and glaucoma.
"This gift to establish the center will enable us to test new, targeted cell therapies, which have the potential to transform our fight against cancer," said Stanford Medicine dean Lloyd Minor. "We are immensely grateful to Jeff and Marieke Rothschild for their commitment to our precision health vision and their foresight in supporting this exciting venture."